Opus Genetics

Opus Genetics is a clinical-stage gene therapy company focused on inherited retinal diseases, featuring a unique model and mission. Backed by RD Fund, the venture arm of Foundation Fighting Blindness, Opus combines unparalleled insight into patient needs and commitment with wholly-owned programs targeting numerous orphan retinal conditions. Its portfolio of AAV-based gene therapies addresses some of the most overlooked forms of inherited blindness while establishing new levels of scale and efficiency in orphan drug manufacturing.